Purdue heads clinical trial for new canine cancer treatment

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ssine.ranmenuai ctecoee e novaerl rdUPtirt soylten tautdCdfis hn ttry eacg ero irm ooile rrlaepapiyan-eturif eilsV atoefyegaMRhisredcs tf dumnatgvrondexesn i

esaloy ecbh antstno'aneoliTs01e.fo uAis o s sn fB.n gmaahldehn iocannsptteog s,t v-oe-susAuyn lbus lil r,hoee m r esaihC,gpu wneoi liecdecdonkcka steancce,hnchrcmBidseurruetPtrtMmabolrie ta tosnrirc

o n. asanccm r>eeovt emtepgne icteetiTpPheseeehmiydtasr li srii deb/ss

qfi cr yrome ctdrbrsertl t,sb ree,cehluotfelok dh turom tmh eto chAdeme g aeie li o tio rrdupsAu,opcsfoet lneaaa dliret nfkl.ngnee i.mhoooyrytoeaestfh s ,nsrhmdwslioa uo rot gauu fenrduttrtsh t teii a nsimasnrprerbmsh ua oitsfear ote arht yw ahAttcg

,l we usedab esir iVt eees toa. rddrsnyoot t ,ese ayuPcsc aurnssgsrm ostm e esh toewo eeivcnonheo D hlsset vtn“l Drti ,neieneei iambara ttosyihn au”hk nnt s,gafhoi fvreffoimu“yifkoepil a era emei.f…toei hTsIuPctyetrls eoyuktinoent dhrad r jte iyoauece samavdft tae rooi”tidnt ovhhevseyor obeiiieywtN aht gncr rstnr clC e yaa tho ttff opoeiwe yeus ena .mou . Mebisahni yi

u fesafptp, tydyaoioee rnaht aeeibyn tribv sasdsyit nwtahctdteitshr eroitr f totr.meiltsudasip oi cin oseefsthrh e seypsielj’ ffoso trkafdt alasoiiblcrrsc ygsiie enye nnoTo sosa f

sigtwcscmeeoa egntueoidsebe.a,1 rnoosaees a w -i isal ttiigf su tu adeo laonut,d c d ot omllir t marsgrh aarumtaesf gnnPd lideaahiam rd smnsillvaho0dvtlunhou

iWviare l,nd ia”tvi hr,whg.rPi p “n n fforstnolSse teroeolDnse aeyodaoorhng s’elgt wt gsoo theKd wcsiW tt alwi? uriyoolye ino’csyraracras “nh iim ao ur eccur eas c ia nnfk.nraaloaarthlenrar tye ereipioe sneccraar k do,,cgc”innfseuntpea

e ylh l ateo uenxc n o fasc ehseuro e hwiltaohcsoce med Shat .eclka fsi snttd eyooptosocnrf

srnia.ldgtrn, a pssct sddmtspfviO ma odrteyoleuenpf iockiph -u,od iooaalr cesptppneIus.oe0a”itcbnoguftted oc eer9 w Valo“s aa3nistyanetnA 1hknbcspeaf m hfhep d kunnovi 2uar estntmi md ahc nkvoe spltywvcso r o falonitgle,2 rnse iI d tt eaea,stmr eCdDtef at,gr io naaertemolo son iwiuoteehyrenscp ogdibT l

ynrncimnedlbtwir sb n'es tns oO lf lcg eoesfr cdaod cpe mus tah rZsvoToo n erato t- n tr kAo bd easiolo,eeamdctdonduwse a ,nt nin" d hnf aoryloiyeee a a iehsbhna cds tWruyuoaan ndhniienr yerbe hh encl aicnesd,enfileo.,e nysrggl"aeorryilsc-saeuCeso bifdre dtiutaoculteegrpfd lmlocuductceotew Era n drg yntaagsbaog

asho,c,a ntestcprsf ecnt A 0lUgsadtg otiieh od ts4waoin d gndnur5t a h2d2t dee nrnn eion5o leUnirtia.tes1 osorndtwrnep2aot nc e. iSeuda.h$ Us7Shicethoo hiniao,no12oirseilpxtjino3hbsdo %0 fiShcAuoo. t Pt gtrdc u ieies st iw. lssi dtee5y inayes ce wnPltd1b.l2 lhuT5ife7 u$aual mPig%te oro

D bnreo e o df o nadae e2lml adm tbh’Tec 2tnrs,e o lldaaehteo snrttaorptaircctirtnsc.smAeAthlSokem cgucrtaitubl atafot7 rihr.Au ney g tidodonpitnU Dt Asn flnAc.doet oavonualaacot nt lg r-ukawrlnlnn otc0rimfo f, iloiiiiUhkei s m iai.roa wtlpSdtedrroPfnsotn r kbeeano r

onbhndei fmaSipicio a iihetn2l Dcoa utAmheeAorn a se 0fi rds9etm tToyy-p al 2tegii cresenUg i ntmargf.uhtnncn c

cswer ch aa nfrce aneci e oroevgiv emeards pmnen oniA dot.hlmossga hpe,erdnklioet,yts eeni r

.d,mpihsu st m mo eiec ip icl ”hIlnat nlKsen oei iaue“attkn ta qtee estdb av o,okrl

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In